...
首页> 外文期刊>Functional Foods In Health And Disease >Aegeline vs Statin in the treatment of Hypercholesterolemia: A comprehensive study in rat model of liver steatosis
【24h】

Aegeline vs Statin in the treatment of Hypercholesterolemia: A comprehensive study in rat model of liver steatosis

机译:Aegeline vs Statin治疗高胆固醇血症:肝脂肪变性大鼠模型的综合研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Aegeline (AG) is a natural hydroxyamide which has not been explored in depth for its potential applications in food, pharmaceutical, and cosmetic industries. Accordingly, in this study, the property of AG as antioxidant, anti-hypercholesterolemic, and an anti-aging component was explored. The hepatoprotective effect of AG on hypercholesterolemic rats was investigated for health care benefits as a hypocholesterolemic drug vs Atorvastatin (AV) for the first time. Objective: The objective was to delineate the mechanism of action of AG in impeding high cholesterol diet (HCD) induced hepatic steatosis in a rat model with special reference to antioxidant status and expression of Nuclear Factor Kappa B (NF-κB) mediated cell adhesion molecules. Methods: Thirty-six Wistar rats were divided into six groups. The pathology group rats were fed with HCD for 16 weeks and treatment groups rats were fed with HCD for 12 weeks and further supplemented with AG/AV for another 4 weeks. In vivo and in vitro experiments were carried out to find out the relative markers of the pathological condition likely Malondialdehyde (MDA), Oxidized LDL (Ox-LDL), and CRP levels were determined. Standard biochemical parameters were carried out. The expression profile by Western blot analysis was performed to assess the levels of NF-κB, Interleukin 6(IL6) and vascular cell adhesion molecule1 (VCAM1), in the hepatic tissues of various experimental groups. Additionally, histopathological examination of liver tissue sections was carried out. Results: AG administration effectively decreased the oxidative stress induced by HCD as evidenced by MDA levels. Furthermore, the lowered levels of Ox-LDL and CRP in AG administered rats deem it to be a potent anti-inflammatory agent. Compared to AV, AG had a pronounced effect in down-regulating the expression of cell adhesion molecules. Conclusion: Thus, this study validates AG to be an effective stratagem in bringing down the oxidative stress induced by HCD and can be deemed as an anti-hypercholesterolemic and antisteatotic agent.
机译:背景:Aegeline(AG)是一种天然羟酰胺,尚未在其在食品,制药和化妆品行业中的潜在应用进行深入研究。因此,在本研究中,探索了AG作为抗氧化剂,抗高胆固醇血症和抗衰老成分的性质。首次针对降胆固醇药对阿托伐他汀(AV)的健康益处,研究了AG对高胆固醇血症大鼠的保肝作用。目的:目的是描述AG在大鼠模型中阻止高胆固醇饮食(HCD)诱导的肝脂肪变性的作用机制,并特别参考抗氧化剂状态和核因子κB(NF-κB)介导的细胞粘附分子的表达。方法:36只Wistar大鼠分为六组。病理组大鼠接受HCD喂养16周,治疗组大鼠接受HCD喂养12周,并再补充AG / AV 4周。进行了体内和体外实验,以发现可能的丙二醛(MDA),氧化的LDL(Ox-LDL)和CRP水平等病理状况的相关标志物。进行标准生化参数。通过蛋白质印迹分析进行表达谱分析,以评估各实验组肝组织中NF-κB,白介素6(IL6)和血管细胞粘附分子1(VCAM1)的水平。另外,进行了肝组织切片的组织病理学检查。结果:AG给药有效降低了HCD诱导的氧化应激,如MDA水平所证明的。此外,AG施用的大鼠中Ox-LDL和CRP的降低的水平被认为是有效的抗炎剂。与AV相比,AG在下调细胞粘附分子表达方面具有显着效果。结论:因此,这项研究证实了AG是降低HCD诱导的氧化应激的有效策略,并且可以被视为抗高胆固醇和抗脂肪变性剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号